TO THE EDITOR Mast cells are necessary for allergic reactions, but they are also important in inflammatory conditions that are worsened by stress (Theoharides and Cochrane, 2004) . Dermatoses, such as atopic dermatitis and psoriasis, are aggravated by stress (Panconesi and Hautmann, 1996; Katsarou-Katsari et al., 1999) . Acute stress or intradermal administration of corticotropin-releasing hormone (CRH) can activate skin mast cells (Theoharides et al., 1998; Singh et al., 1999) that are located perivascularly close to nerve endings. CRH and CRH receptor (CRH-R) mRNA are expressed in human and rodent skin (Slominski et al., 1995 , in association with the hair cycle (Roloff et al., 1998; Pisarchik and Slominski, 2001) . Increased CRH-R1 gene expression was documented in the affected skin from patients with chronic urticaria (Papadopoulou et al., 2005) . Moreover, CRH-R1 is involved in the stress-induced exacerbation of chronic contact dermatitis in rats (Kaneko et al., 2003) . Mast cells could be unique targets of CRH and related peptides, contributing to neurogenic inflammation .
Here, in situ hybridization and immunohistochemistry (IHC) were used to localize CRH-R on mouse skin mast cells. Mouse skin sections hybridized with 33 P-labeled antisense CRH-R1 riboprobe displayed silver grains in the outer root sheath of hair follicles ( Figure  1a) . Clusters of signal were also associated with certain perifollicular cells (Figure 1b ) with morphological characteristics of mast cells: fairly large size, irregular shape, and perivascular localization. A skin section hybridized with 33 P-labeled sense CRH-R1 probe displayed no specific labeling (Figure 1c ). To confirm whether mast cells express CRH-R protein, IHC was performed, and the sections were subsequently stained with toluidine blue, a histological stain for mast cells. The distribution and morphology of the perifollicular cells expressing CRH-R1 mRNA ( Figure  1b ) determined by in situ hybridization, was virtually identical to the CRH-Rlike immunoreactivity detected using IHC ( Figure 2a) ; these perifollicular cells stained with toluidine blue ( Figure  2b ). CRH-R-like immunoreactivity (Figure 2c ) was also present on toluidine blue positive cells found adjacent to blood vessels, (Figure 2d ). The present results suggest that a small population of perifollicular and perivascular skin mast cells express CRH-R. The findings were confirmed recently with FACS analysis of a population of disaggregated skin cells double positive for CRH-R and the mast cell growth factor receptor c-kit (Donelan et al., 2006) . Previous reports have shown CRH-R1 expression in the outer root sheath, hair matrix, and dermal papilla of mouse skin (Slominski et al., , 2001 Roloff et al., 1998) . CRH-R2 expression in the epidermis, hair follicle, and sebaceous glands of rodents had been reported by molecular and immunological detection (Slominski et al., 2004) .
The expression of CRH-R1 in and around the hair follicle may help explain stress-induced hair loss. Expression of different CRH-R1 isoforms is hair cycle dependent; whereas CRHR1a is absent in telogen, it is present in anagen (Pisarchik and Slominski, 2001) , which may explain differential responsiveness of mouse skin to CRH ligands. During the cyclic remodeling of the hair follicle, the perifollicular innervation undergoes significant changes in sensory skin innervation and in mast cell-nerve contacts (Peters et al., 2001) ; perifollicular mast cells also modulate hair follicle cycling (Paus et al., 1994) . Moreover, the hair follicle was recently identified as a major source of skin mast cell progenitors (Kumamoto et al., 2003) .
Murine hair growth in vivo and in situ is modulated by stress response mediators that can act as endogenous mast cell secretagogues (Peters et al., 2004) . Sound-induced psychological stress was shown to increase the number of apoptotic cells in the hair follicle and significantly increase the number of degranulated mast cells (Arck et al., 2001) ; these effects could be mimicked by injection with the neuropeptide substance P. In the absence of functional mast cells or the substance P receptor NK-1R, stress failed to induce premature hair follicle regression (Arck et al., 2005) . In addition to substance P, neurotensin (Singh et al., 1999) could activate skin mast cells and it was recently shown that the intradermal effect of CRH on vascular permeability was dependent on neurotensin (Donelan et al., 2006) .
Acute stress increases CRH in the skin of rodents (Lytinas et al., 2003) and intradermal CRH administration in rats leads to activation of skin mast cells and increased vascular permeability (Theoharides et al., 1998) . Both CRH and its structurally related peptide urocortin are produced by human skin cells (Slominski et al., 1998; , whereas mice only produce urocortin . In mice, CRH is delivered to the skin by nerve endings (Slominski et al., , 1999 . CRH administration in humans causes peripheral skin vasodilation and flushing dependent on CRH-R1 and mast cells (Crompton et al., 2003) . Human mast cells express mRNA and protein for a number of CRH-R1 isoforms and CRH-R2 (Cao et al., 2005) , suggesting there could be autocrine effects. Human mast cells synthesize both CRH and urocortin that could be released in response to immunologic stimulation (Theoharides and Cochrane, 2004) . Mast cells can secrete histamine and tryptase, which can stimulate proteinase-activated receptors on sensory neurons, which in turn enhance the inflammatory response via the release of additional substance P (Steinhoff et al., 2000) . Mast cells can also secrete vascular endothelial growth factor, an isoform of which is vasodilatory (Grutzkau et al., 1998) . In fact, CRH could stimulate selective release of vascular endothelial growth factor (Cao et al., 2005) , which is overexpressed in psoriatic skin and in delayed hypersensitivity reactions (Brown et al., 1995) ; moreover, overexpression of vascular endothelial growth factor in mouse skin was shown to lead to skin inflammation resembling psoriasis (Xia et al., 2003) .
The skin has been shown to have a peripheral equivalent of the hypothalamic-pituitary-adrenal axis (Slominski and Mihm, 1996; Ito et al., 2005; Slominski et al., 2005a, b) . A ''brain-skin connection'' that involves the hair follicle, neuropeptides, and mast cells has been implicated in the pathogenesis of allergic and inflammatory skin diseases exacerbated by stress (Paus et al., 2006) . The present findings indicate that a subpopulation of skin mast cells are involved in these processes.
MATERIALS AND METHODS

In situ Hybridization
Male 25-30 g C57BL/6 mice (Charles River, NY) were anesthetized with intraperitoneal administration of ketamine/xylazine (100 and 20 mg/kg each) and killed by decapitation. The fur was removed and the skin was dissected, immediately frozen in Tissue-Tek embedding medium and stored at À801C. Sections (7 mm thick) were cut on a cryostat, were adhered to slides at room temperature, and were stored at À801C before in situ hybridization. These experiments were approved by the Tufts University Intstitutional Animal Care and Use Committee.
CRH-R1 Probes
A 700 bp fragment of the 5 0 end of mouse CRH-R1 coding region was subcloned into the pcDNA-1 expression vector (Invitrogen, Eugene, OR) that contains the T7 and Sp6 RNA polymerase promoter sequence. T7 and Sp6 RNA polymerase were used to transcribe the cRNA for CRH-R1 from linearized plasmids. CRH-R1 cRNA transcripts were labeled using T3 polymerase and [a-33 P]UTP (10 mCi/ml) by a standard transcription reaction (Marchand, 1992 (Marchand, , 1994 Hybridization procedure. Tissue sections were thawed and fixed in 4% paraformaldehyde for 15 minutes at room temperature. After fixation, skin sections from the same experiment were hybridized together for single-labeled autoradiographic in situ hybridization as described previously (Cain et al., 2003) .
IHC for CRH-R
IHC was performed on mouse skin sections using a CRH-RI/II rabbit polyclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) together with the DAKO EnVision þ System-HRP (DAB) (DakoCytomation, Carpinteria, CA). Cryostat sections (7 mm) were prepared from mouse skin and fixed with Bouin's fixative for 5 minutes and incubated with endogenous peroxidase blocking reagent for an additional 5 minutes. The sections were incubated with primary antibody (1:75-1:200 dilution) overnight at 41C. The following day, the sections were incubated in goat anti-rabbit Ig conjugated to horseradish peroxidase for 45 minutes followed by addition of the substrate chromogen DAB for 10 minutes. The sections were rinsed in Tris-buffered saline for 5 minutes between incubations. Negative controls were performed by the omission of the primary antibody or its substitution by a naive isotypic antibody. A blocking/neutralizing peptide was not available from Santa Cruz because the CRH-R antibody used was raised against a recombinant peptide and not a peptide antigen. 
